These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1780043)

  • 1. Chronic inhibition of enkephalinase induces changes in the antinociceptive and locomotor effects of the enkephalinase inhibitor acetorphan in rats.
    Bousselmame R; Eustache M; Michael-Titus A; Costentin J
    Neuropharmacology; 1991 Aug; 30(8):865-70. PubMed ID: 1780043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor and analgesic effects of morphine and acetorphan in rats chronically treated with morphine or thiorphan.
    Khallouk-Bousselmame R; Costentin J
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):137-43. PubMed ID: 7919943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor.
    Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented analgesic effects of enkephalinase inhibitors combined with transcranial electrostimulation.
    Malin DH; Lake JR; Hamilton RF; Skolnick MH
    Life Sci; 1989; 44(19):1371-6. PubMed ID: 2716474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects.
    Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM
    J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endogenous enkephalins in locomotion and nociception studied with peptidase inhibitors in two inbred strains of mice (C57BL/6J and DBA/2J).
    Michael-Titus A; Dourmap N; Caline H; Costentin J; Schwartz JC
    Neuropharmacology; 1989 Feb; 28(2):117-22. PubMed ID: 2716968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic potency of S-acetylthiorphan after intravenous administration to mice.
    Lambert DM; Mergen F; Poupaert JH; Dumont P
    Eur J Pharmacol; 1993 Oct; 243(2):129-34. PubMed ID: 8276061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally administered [D-Trp11]neurotensin, as well as neurotensin protected from inactivation by thiorphan, modifies locomotion in rats in a biphasic manner.
    Nouel D; Dubuc I; Kitabgi P; Costentin J
    Peptides; 1990; 11(3):551-5. PubMed ID: 2381875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin of the stimulation of food intake by oral administration of enkephalinase inhibitors in sheep.
    Rivière PJ; Buéno L
    Life Sci; 1987 Jul; 41(3):333-9. PubMed ID: 3298911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of mu-opioid receptors does not modify the analgesia induced by an enkephalinase inhibitor.
    Bousselmame R; Michael-Titus A; Costentin J
    Eur J Pharmacol; 1991 Oct; 203(2):295-7. PubMed ID: 1666049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the abuse potential of acetorphan, an enkephalinase inhibitor.
    Knisely JS; Beardsley PM; Aceto MD; Balster RL; Harris LS
    Drug Alcohol Depend; 1989 Apr; 23(2):143-51. PubMed ID: 2702924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of enkephalinase inhibition in the living mouse, using [3H]acetorphan as a probe.
    De la Baume S; Brion F; Dam Trung Tuong M; Schwartz JC
    J Pharmacol Exp Ther; 1988 Nov; 247(2):653-60. PubMed ID: 3183961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral excitatory effects of two enkephalinase inhibitors, acetorphan and thiorphan, and an enkephalin analogue, [D-Ala2-Met5]-enkephalinamide, on uterine motility in periparturient rats in vivo and in vitro.
    Adjroud O
    J Reprod Fertil; 1995 Jul; 104(2):181-6. PubMed ID: 7473405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous enkephalins in locomotion evidenced by acetorphan, an "enkephalinase" inhibitor.
    Michael-Titus A; Preterre P; Giros B; Costentin J
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1062-6. PubMed ID: 3121843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of 2-[S-acetylthiorphan]-1,3- diacylaminopropan-2-ol derivatives as chimeric lipid drug carriers containing an enkephalinase inhibitor.
    Lambert DM; Mergen F; Berens CF; Poupaert JH; Dumont P
    Pharm Res; 1995 Feb; 12(2):187-91. PubMed ID: 7784331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
    Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
    Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diuretic and natriuretic responses in rats treated with enkephalinase inhibitors.
    Bralet J; Mossiat C; Lecomte JM; Charpentier S; Gros C; Schwartz JC
    Eur J Pharmacol; 1990 Apr; 179(1-2):57-64. PubMed ID: 2142087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of orally active enkephalinase inhibitors on morphine withdrawal syndrome.
    Dzoljic MR; Bokszanska A; Korenhof AM; Kaplan CD; Dzoljic M; Rupreht J; Zijlstra FJ; Brinkman EC; Cappendijk SL
    Neuroreport; 1992 Jul; 3(7):637-40. PubMed ID: 1421123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thiorphan and acetorphan inhibit gastric secretion by a central, non-opioid mechanism in the rat.
    Chicau-Chovet M; Dubrasquet M; Chariot J; Tsocas A; Lecomte JM; Rozé C
    Eur J Pharmacol; 1988 Sep; 154(3):247-54. PubMed ID: 3234479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrathecal administration of thiorphan, bestatin, desipramine and fluoxetine differentially potentiate the antinociceptive effects induced by beta-endorphin and morphine, administered intracerebroventricularly.
    Suh HH; Tseng LL
    Neuropharmacology; 1990 Mar; 29(3):207-14. PubMed ID: 2139187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.